Colocalization of CART peptide with prodynorphin and dopamine D1 receptors in the rat nucleus accumbens

Neuropeptides

Volumn 40, Issue 6, 2006, Pages 409-415

  Hubert, George W ^a   Kuhar, Michael J ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Drug abuse; Neuropeptides; Nucleus accumbens

Indexed keywords

COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; DOPAMINE 1 RECEPTOR; PRODYNORPHIN;

ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CELLULAR DISTRIBUTION; DEFENSE MECHANISM; IMMUNOREACTIVITY; INFORMATION PROCESSING; MALE; NERVE CELL; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

ANIMALS; COCAINE; ENKEPHALINS; MALE; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NEURONS; NEUROPEPTIDES; NUCLEUS ACCUMBENS; PEPTIDES; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; SUBSTANCE-RELATED DISORDERS;

EID: 33750947281     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2006.09.001     Document Type: Article

References (65)

1. Angulo J.A., and McEwen B.S. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Brain Res. Rev. 19 (1994) 1-28
2. Bayon A., Koda L., Battenberg E., and Bloom F.E. Redistribution of endorphin and enkephalin immunoreactivity in the rat brain and pituitary after in vivo treatment with colchicine or cytochalasin B. Brain Res. 183 (1980) 103-111
3. Beaudry G., Zekki H., Rouillard C., and Levesque D. Clozapine and dopamine D3 receptor antisense reduce cocaine- and amphetamine-regulated transcript expression in the rat nucleus accumbens shell. Synapse 51 (2004) 233-240
4. Ben-Chetrit E., Bergmann S., and Sood R. Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: a possible new outlook through microarray analysis. Rheumatology (Oxford) 45 (2006) 274-282
5. Brenz Verca M.S., Widmer D.A., Wagner G.C., and Dreyer J. Cocaine-induced expression of the tetraspanin CD81 and its relation to hypothalamic function. Mol. Cell Neurosci. 17 (2001) 303-316
6. Couceyro P., Koylu E., and Kuhar M. Further studies on the anatomical distribution of CART by in situ hybridization. J. Chem. Neuroanat. 12 (1997) 229-241
7. Couceyro P.R., and Lambert P.D. CART peptides: therapeutic potential in obesity and feeding disorders. Drug News Perspect. 12 (1999) 133-136
8. Couceyro P.R., Evans C., McKinzie A., Mitchell D., Dube M., Hagshenas L., White F.J., Douglass J., Richards W.G., and Bannon A.W. Cocaine- and amphetamine-regulated transcript (CART) peptides modulate the locomotor and motivational properties of psychostimulants. J. Pharmacol. Exp. Ther. 315 (2005) 1091-1100
9. Dallvechia-Adams S., Smith Y., and Kuhar M.J. CART peptide-immunoreactive projection from the nucleus accumbens targets substantia nigra pars reticulata neurons in the rat. J. Comp. Neurol. 434 (2001) 29-39
10. Dallvechia-Adams S., Kuhar M.J., and Smith Y. Cocaine- and amphetamine-regulated transcript peptide projections in the ventral midbrain: colocalization with gamma-aminobutyric acid, melanin-concentrating hormone, dynorphin, and synaptic interactions with dopamine neurons. J. Comp. Neurol. 448 (2002) 360-372
11. Douglass J., and Daoud S. Characterization of the human cDNA and genomic DNA encoding CART: a cocaine- and amphetamine-regulated transcript. Gene 169 (1996) 241-245
12. Douglass J., McKinzie A.A., and Couceyro P. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J. Neurosci. 15 (1995) 2471-2481
13. Fagergren P., and Hurd Y.L. Mesolimbic gender differences in peptide CART mRNA expression: effects of cocaine. Neuroreport 10 (1999) 3449-3452
14. Funada M., Suzuki T., Narita M., Misawa M., and Nagase H. Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Neuropharmacology 32 (1993) 1315-1323
15. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Ann. Rev. Neurosci. 15 (1992) 285-320
16. Grech D.M., Spealman R.D., and Bergman J. Self-administration of D1 receptor agonists by squirrel monkeys. Psychopharmacology (Berl) 125 (1996) 97-104
17. Haberny S.L., and Carr K.D. Comparison of basal and D-1 dopamine receptor agonist-stimulated neuropeptide gene expression in caudate-putamen and nucleus accumbens of ad libitum fed and food-restricted rats. Brain Res. Mol. Brain Res. 141 (2005) 121-127
18. Hara Y., Yakovleva T., Bakalkin G., and Pickel V.M. Dopamine D1 receptors have subcellular distributions conducive to interactions with prodynorphin in the rat nucleus accumbens shell. Synapse 60 (2006) 1-19
19. Hubert G.W., and Kuhar M.J. Colocalization of CART with substance P but not enkephalin in the rat nucleus accumbens. Brain Res. 1050 (2005) 8-14
20. Hunter R. Regulation of CART by dopamine in the nucleus accumbens of the rat. Molecular and Systems Pharmacology (2005), Emory University, Atlanta p. 108
21. Hunter R.G., Vicentic A., Rogge G., and Kuhar M.J. The effects of cocaine on CART expression in the rat nucleus accumbens: a possible role for corticosterone. Eur. J. Pharmacol. 517 (2005) 45-50
22. Hunter R.G., Philpot K., Vicentic A., Dominguez G., Hubert G.W., and Kuhar M.J. CART in feeding and obesity. Trends Endocrinol. Metab. 15 (2004) 454-459
23. Hunter R.G., Jones D., Vicentic A., Hue G., Rye D., and Kuhar M.J. Regulation of CART mRNA in the rat nucleus accumbens via D3 dopamine receptors. Neuropharmacology 50 (2006) 858-864
24. Hurd Y.L., and Herkenham M. The human neostriatum shows compartmentalization of neuropeptide gene expression in dorsal and ventral regions: an in situ hybridization histochemical analysis. Neuroscience 64 (1995) 571-586
25. Hurd Y.L., Svensson P., and Ponten M. The role of dopamine, dynorphin, and CART systems in the ventral striatum and amygdala in cocaine abuse. Ann. N. Y. Acad. Sci. 877 (1999) 499-506
26. Ikemoto S., Glazier B.S., Murphy J.M., and McBride W.J. Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. J. Neurosci. 17 (1997) 8580-8587
27. Jaworski J.N., Kozel M.A., Philpot K.B., and Kuhar M.J. Intra-accumbal injection of CART (cocaine-amphetamine regulated transcript) peptide reduces cocaine-induced locomotor activity. J. Pharmacol. Exp. Ther. 307 (2003) 1038-1044
28. Jaworski J.N., Vicentic A., Hunter R.G., Kimmel H.L., and Kuhar M.J. CART peptides are modulators of mesolimbic dopamine and psychostimulants. Life Sci. 73 (2003) 741-747
29. Jones D.C., and Kuhar M.J. Cocaine-amphetamine-regulated transcript expression in the rat nucleus accumbens is regulated by adenylyl cyclase and the cyclic adenosine 5′-monophosphate/protein kinase a second messenger system. J. Pharmacol. Exp. Ther. 317 (2006) 454-461
30. Kim J.H., Creekmore E., and Vezina P. Microinjection of CART peptide 55-102 into the nucleus accumbens blocks amphetamine-induced locomotion. Neuropeptides 37 (2003) 369-373
31. Kimmel H.L., Gong W., Vechia S.D., Hunter R.G., and Kuhar M.J. Intra-ventral tegmental area injection of rat cocaine and amphetamine-regulated transcript peptide 55-102 induces locomotor activity and promotes conditioned place preference. J. Pharmacol. Exp. Ther. 294 (2000) 784-792
32. Koob G.F. The role of the striatopallidal and extended amygdala systems in drug addiction. Ann. N. Y. Acad. Sci. 877 (1999) 445-460
33. Koob G.F., and Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 278 (1997) 52-58
34. Koylu E.O., Couceyro P.R., Lambert P.D., and Kuhar M.J. Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J. Comp. Neurol. 391 (1998) 115-132
35. Koylu E.O., Couceyro P.R., Lambert P.D., Ling N.C., DeSouza E.B., and Kuhar M.J. Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland. J. Neuroendocrinol. 9 (1997) 823-833
36. Kuhar M.J., Adams L.D., Hunter R.G., Vechia S.D., and Smith Y. CART peptides. Regul. Pept. 89 (2000) 1-6
37. Kuhar M.J., Adams S., Dominguez G., Jaworski J., and Balkan B. CART peptides. Neuropeptides 36 (2002) 1-8
38. Kuhar M.J., Jaworski J.N., Hubert G.W., Philpot K.B., and Dominguez G. Cocaine- and amphetamine-regulated transcript peptides play a role in drug abuse and are potential therapeutic targets. Aaps J. 7 (2005) E259-E265
39. Levey A.I., Hersch S.M., Rye D.B., Sunahara R.K., Niznik H.B., Kitt C.A., Price D.L., Maggio R., Brann M.R., Ciliax B.J., et al. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc. Natl. Acad. Sci. USA 90 (1993) 8861-8865
40. Mao L., Conquet F., and Wang J.Q. Augmented motor activity and reduced striatal preprodynorphin mRNA induction in response to acute amphetamine administration in metabotropic glutamate receptor 1 knockout mice. Neuroscience 106 (2001) 303-312
41. Muller G.J., Geist M.A., Veng L.M., Willesen M.G., Johansen F.F., Leist M., and Vaudano E. A role for mixed lineage kinases in granule cell apoptosis induced by cytoskeletal disruption. J. Neurochem. 96 (2006) 1242-1252
42. Ogden C.A., Rich M.E., Schork N.J., Paulus M.P., Geyer M.A., Lohr J.B., Kuczenski R., and Niculescu A.B. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol. Psychiatry 9 (2004) 1007-1029
43. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. fourth ed. (1986), Academic Press, New York
44. Philpot K.B., Dallvechia-Adams S., Smith Y., and Kuhar M.J. A cocaine-and-amphetamine-regulated-transcript peptide projection from the lateral hypothalamus to the ventral tegmental area. Neuroscience 135 (2005) 915-925
45. Pickel V.M., Chan J., and Sesack S.R. Cellular substrates for interactions between dynorphin terminals and dopamine dendrites in rat ventral tegmental area and substantia nigra. Brain Res. 602 (1993) 275-289
46. Ritz M.C., Lamb R.J., Goldberg S.R., and Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237 (1987) 1219-1223
47. Self D.W. Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology 47 Suppl. 1 (2004) 242-255
48. Shieh K.R. Effects of the cocaine- and amphetamine-regulated transcript peptide on the turnover of central dopaminergic neurons. Neuropharmacology 44 (2003) 940-948
49. Shippenberg T.S., and Rea W. Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists. Pharmacol. Biochem. Behav. 57 (1997) 449-455
50. Singh J., Desiraju T., Nagaraja T.N., and Raju T.R. Facilitation of self-stimulation of ventral tegmentum by microinjection of opioid receptor subtype agonists. Physiol. Behav. 55 (1994) 627-631
51. Smith Y., Koylu E.O., Couceyro P., and Kuhar M.J. Ultrastructural localization of CART (cocaine- and amphetamine-regulated transcript) peptides in the nucleus accumbens of monkeys. Synapse 27 (1997) 90-94
52. Smith Y., Kieval J., Couceyro P.R., and Kuhar M.J. CART peptide-immunoreactive neurones in the nucleus accumbens in monkeys: ultrastructural analysis, colocalization studies, and synaptic interactions with dopaminergic afferents. J. Comp. Neurol. 407 (1999) 491-511
53. Smith Y., Pare J.-F., Koylu E., Couceyro P., Ince E., Levey A.I., and Kuhar M.J. CART peptide immunoreactivity in the nucleus accumbens of monkeys: electron microscopic analysis and co-localization studies. Soc. Neurosci. Abstr. 23 (1997) 384-386
54. Steiner H., and Gerfen C.R. Dynorphin regulates D1 dopamine receptor-mediated responses in the striatum: relative contributions of pre- and postsynaptic mechanisms in dorsal and ventral striatum demonstrated by altered immediate-early gene induction. J. Comp. Neurol. 376 (1996) 530-541
55. Steiner H., and Gerfen C.R. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp. Brain Res. 123 (1998) 60-76
56. Thim L., Kristensen P., Larsen P.J., and Wulff B.S. CART, a new anorectic peptide. Int. J. Biochem. Cell Biol. 30 (1998) 1281-1284
57. Tran A.H., Tamura R., Uwano T., Kobayashi T., Katsuki M., and Ono T. Dopamine D1 receptors involved in locomotor activity and accumbens neural responses to prediction of reward associated with place. Proc. Natl. Acad. Sci. USA 102 (2005) 2117-2122
58. Vaarmann A., and Kask A. Cocaine and amphetamine-regulated transcript peptide (CART(62-76))-induced changes in regional monoamine levels in rat brain. Neuropeptides 35 (2001) 292-296
59. Vrang N., Larsen P.J., Clausen J.T., and Kristensen P. Neurochemical characterization of hypothalamic cocaine-amphetamine-regulated transcript neurons. J. Neurosci. 19 (1999) RC5
60. Wichmann T., and DeLong M.R. Functional and pathophysiological models of the basal ganglia. Curr. Opin. Neurobiol. 6 (1996) 751-758
61. Zahm D.S. Functional-anatomical implications of the nucleus accumbens core and shell subterritories. Ann. N. Y. Acad. Sci. 877 (1999) 113-128
62. Zhang Y., Butelman E.R., Schlussman S.D., Ho A., and Kreek M.J. Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice. Psychopharmacology (Berl) 172 (2004) 422-429
63. Zhang Y., Butelman E.R., Schlussman S.D., Ho A., and Kreek M.J. Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice. Psychopharmacology (Berl) 173 (2004) 146-152
64. Zhang Y., Butelman E.R., Schlussman S.D., Ho A., and Kreek M.J. Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors. Psychopharmacology (Berl) 179 (2005) 551-558
65. Zhou L., Furuta T., and Kaneko T. Chemical organization of projection neurons in the rat accumbens nucleus and olfactory tubercle. Neuroscience 120 (2003) 783-798